Literature DB >> 1261309

Editorial: Pulmonary hypertension and oral contraceptive usage.

A T Masi.   

Abstract

Entities:  

Keywords:  Contraception; Contraceptive Methods--side effects; Diseases; Family Planning; Hypertension; Oral Contraceptives--side effects; Vascular Diseases

Mesh：

Substances：

Year:  1976        PMID： 1261309     DOI： 10.1378/chest.69.4.451b

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  7 in total

Review 1.  Sex differences and sex steroids in lung health and disease.

Authors:  Elizabeth A Townsend; Virginia M Miller; Y S Prakash
Journal:  Endocr Rev       Date:  2012-01-12       Impact factor: 19.871

Review 2.  Drug-induced pulmonary vascular disease--mechanisms and clinical patterns.

Authors:  K Kumar; W E Holden
Journal:  West J Med       Date:  1986-09

Review 3.  Drug-induced respiratory disorders: incidence, prevention and management.

Authors:  L Ben-Noun
Journal:  Drug Saf       Date:  2000-08       Impact factor: 5.606

Review 4.  Pulmonary hypertension, sleep-disordered breathing, and beta blockers in heart failure patients.

Authors:  Robert P Blankfield
Journal:  Sleep Breath       Date:  2002-12       Impact factor: 2.816

5.  Serotonin transporter, sex, and hypoxia: microarray analysis in the pulmonary arteries of mice identifies genes with relevance to human PAH.

Authors:  Kevin White; Lynn Loughlin; Zakia Maqbool; Margaret Nilsen; John McClure; Yvonne Dempsie; Andrew H Baker; Margaret R MacLean
Journal:  Physiol Genomics       Date:  2011-02-08       Impact factor: 3.107

Review 6.  Newer insights into the pathobiological and pharmacological basis of the sex disparity in patients with pulmonary arterial hypertension.

Authors:  Tanvirul Hye; Pankaj Dwivedi; Wei Li; Tim Lahm; Eva Nozik-Grayck; Kurt R Stenmark; Fakhrul Ahsan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-03-10       Impact factor: 6.011

Review 7.  Pulmonary arterial hypertension: basis of sex differences in incidence and treatment response.

Authors:  K M Mair; A K Z Johansen; A F Wright; E Wallace; M R MacLean
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.